Synopsis
Synopsis
0
JDMF
0
VMF
0
FDF
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. A 45975
2. Adecur
3. Apo-terazosin
4. Deflox
5. Dysalfa
6. Flotrin
7. Heitrin
8. Hytrin
9. Hytrin Bph
10. Hytrine
11. Magnurol
12. Novo-terazosin
13. Nu-terazosin
14. Pms-terazosin
15. Ratio-terazosin
16. Sutif
17. Tazusin
18. Terazoflo
19. Terazosin
20. Terazosin Azu
21. Terazosin Hexal
22. Terazosin Hydrochloride Anhydrous
23. Terazosin, Monohydrochloride, Dihydrate
24. Terazosina Alter
25. Terazosina Kern
26. Terazosina Qualix
27. Zayasel
1. 63074-08-8
2. Terazosin Hcl
3. Hytrin
4. Fosfomic
5. Zayasel
6. Blavin
7. Terazosin Hydrochloride Anhydrous
8. Vasocard
9. (4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl)(tetrahydrofuran-2-yl)methanone Hydrochloride
10. Flumarc
11. Mls000040261
12. Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)-, Monohydrochloride
13. Terazosin (hydrochloride)
14. 8qop8z9955
15. Terazocin Hydrochloride (anhydrous)
16. Smr000044015
17. Dsstox_cid_25493
18. Dsstox_rid_80913
19. Dsstox_gsid_45493
20. 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]piperazine Hydrochloride
21. 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)4-[(tetrahydro-2-furanyl)carbonyl]piperazine Hydrochloride
22. Abbott-45975 Anhydrous
23. Cas-63074-08-8
24. Sr-01000000197
25. Unii-8qop8z9955
26. Prestwick_146
27. Opera_id_398
28. Ncgc00016903-01
29. Schembl41545
30. Terazosin Hydrochloride,pharma
31. Mls001077301
32. Mls001305722
33. Chembl1256665
34. Dtxsid7045493
35. Hy-b0371f
36. Hms1570g04
37. Pharmakon1600-01505576
38. Bcp12795
39. Terazosin Hydrochloride [mi]
40. Tox21_110674
41. Mfcd00467965
42. Nsc759168
43. S4679
44. Akos007930686
45. Tox21_110674_1
46. Ac-2074
47. Ccg-220751
48. Lp01138
49. Ncgc00016026-10
50. Ncgc00094404-01
51. Ncgc00094404-02
52. Terazosin Hydrochloride, Anhydrous
53. Ds-11401
54. Db-018541
55. Cs-0013075
56. Eu-0101138
57. Ft-0605647
58. T2751
59. D11585
60. D70611
61. T 4680
62. Terazosin Hydrochloride, >=98% (tlc), Powder
63. 074t088
64. Terazosin Hydrochloride Anhydrous [who-dd]
65. Sr-01000000197-2
66. Sr-01000000197-4
67. Q27270906
68. Sr-01000000197-12
69. 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)-piperazine Hydrochloride
70. 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine Hydrochloride
71. 2[4-(tetrahydro-2-furoy1)piperazinyl]-4-amino-6,7-dimethoxyquinazoline Hydrochloride
72. 4-amino-6,7-dimethoxy-2-[4-(tetrahydro-2-furoyl)-1-piperazinyl]quinazoline Hydrochloride
73. (4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl)(tetrahydrofuran-2-yl)methanonehydrochloride
74. [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(oxolan-2-yl)methanone;hydrochloride
75. [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(oxolan-2-yl)methanone;hydron;chloride
76. 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]-piperazine Hydrochloride
77. Methanone, (4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl)(tetrahydro-2-furanyl)-, Hydrochloride (1:1)
78. Piperazine,1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]-, Monohydrochloride
Molecular Weight | 423.9 g/mol |
---|---|
Molecular Formula | C19H26ClN5O4 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 4 |
Exact Mass | 423.1673320 g/mol |
Monoisotopic Mass | 423.1673320 g/mol |
Topological Polar Surface Area | 103 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 544 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Terazosin hydrochloride |
Drug Label | Terazosin hydrochloride, an alpha-1-selective adrenoceptor blocking agent, is a quinazoline derivative represented by the following chemical name and structural formula: (RS)-Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furan... |
Active Ingredient | Terazosin hydrochloride |
Dosage Form | Capsule |
Route | Oral |
Strength | eq 5mg base; eq 2mg base; eq 1mg base; eq 10mg base |
Market Status | Prescription |
Company | Jubilant Cadista; Apotex; Sandoz; Ivax Sub Teva Pharms; Mylan |
2 of 2 | |
---|---|
Drug Name | Terazosin hydrochloride |
Drug Label | Terazosin hydrochloride, an alpha-1-selective adrenoceptor blocking agent, is a quinazoline derivative represented by the following chemical name and structural formula: (RS)-Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furan... |
Active Ingredient | Terazosin hydrochloride |
Dosage Form | Capsule |
Route | Oral |
Strength | eq 5mg base; eq 2mg base; eq 1mg base; eq 10mg base |
Market Status | Prescription |
Company | Jubilant Cadista; Apotex; Sandoz; Ivax Sub Teva Pharms; Mylan |
Urological Agents
Drugs used in the treatment of urological conditions and diseases such as URINARY INCONTINENCE and URINARY TRACT INFECTIONS. (See all compounds classified as Urological Agents.)
Adrenergic alpha-1 Receptor Antagonists
Drugs that bind to and block the activation of ADRENERGIC ALPHA-1 RECEPTORS. (See all compounds classified as Adrenergic alpha-1 Receptor Antagonists.)
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37577
Submission : 2022-10-31
Status : Active
Type : II
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 10035
Submission : 1993-01-11
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12244
Submission : 1996-11-25
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12424
Submission : 1997-03-17
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 10319
Submission : 1993-06-24
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12649
Submission : 1997-09-08
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9157
Submission : 1991-06-06
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-03-30
Pay. Date : 2012-11-13
DMF Number : 11300
Submission : 1995-01-16
Status : Active
Type : II
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12581
Submission : 1997-07-08
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 10054
Submission : 1993-01-21
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Terazosin hydrochloride dihydrate
Certificate Number : R1-CEP 2014-214 - Rev 00
Status : Valid
Issue Date : 2022-02-08
Type : Chemical
Substance Number : 2021
Terazosin hydrochloride dihydrate
Certificate Number : R1-CEP 2006-307 - Rev 01
Status : Suspended by EDQM Failure to CEP pro...
Issue Date : 2013-03-21
Type : Chemical
Substance Number : 2021
Terazosin hydrochloride dihydrate
Certificate Number : CEP 2007-092 - Rev 05
Status : Valid
Issue Date : 2023-12-13
Type : Chemical
Substance Number : 2021
Terazosin hydrochloride dihydrate
Certificate Number : R1-CEP 2007-207 - Rev 05
Status : Valid
Issue Date : 2022-04-19
Type : Chemical
Substance Number : 2021
Terazosin hydrochloride dihydrate
Certificate Number : CEP 2022-409 - Rev 00
Status : Valid
Issue Date : 2024-08-30
Type : Chemical
Substance Number : 2021
Date of Issue : 2022-07-15
Valid Till : 2025-07-02
Written Confirmation Number : WC-0120
Address of the Firm : Unit-1, Sy. No. 388 & 389, Borpatla (V), Hatnoora (M), Medak (Dist).502 296 A.P....
Terazosin Hydrochloride Dihydrate USP/EP
Date of Issue : 2022-06-24
Valid Till : 2025-07-02
Written Confirmation Number : WC-0097
Address of the Firm : Block No. 251/P, 252/P, 253 to 255, 256/P,258/P, 276/P, 277/P, 278/P, 279 To 282...
Terazosin Hydrochloride (EP/USP)
Date of Issue : 2022-09-01
Valid Till : 2024-11-04
Written Confirmation Number : WC-0092
Address of the Firm : Plot No. 18, 56, 57 & 58, K.I.A.D.B. Industrial Area\r\nNanjangud - 571 302, Mys...
Registrant Name : Ilyang Pharmaceutical Co., Ltd.
Registration Date : 2013-04-11
Registration Number : 20060707-48-B-224-08(2)
Manufacturer Name : AbbVie Ireland NL BV
Manufacturer Address : Manorhamilton Road, Sligo, Republic of Ireland
Terazosin hydrochloride hydrate
Registrant Name : Abbott Korea Co., Ltd.
Registration Date : 2006-07-07
Registration Number : 20060707-48-B-224-08
Manufacturer Name : AbbVie Ireland NL BV
Manufacturer Address : Manorhamilton Road, Sligo, Republic of Ireland
Registrant Name : Samoh Pharmaceutical Co., Ltd.
Registration Date : 2005-08-31
Registration Number : 20050831-48-B-128-02
Manufacturer Name : Euticals SpA
Manufacturer Address : Viale Europa 5, I-21040 Origgio-Italy
Registrant Name : Samoh Pharmaceutical Co., Ltd.
Registration Date : 2005-09-30
Registration Number : 20050930-48-B-204-07
Manufacturer Name : Asia Chemical Industries Ltd...
Manufacturer Address : Neot-Hovav Eco-Industrial Park, Emek Sara, POB 2049, Be'er Sheva, 8412316, Israel
Registrant Name : Ilyang Pharmaceutical Co., Ltd.
Registration Date : 2015-05-12
Registration Number : 20050930-48-B-204-07(1)
Manufacturer Name : Asia Chemical Industries Ltd...
Manufacturer Address : Neot-Hovav Eco-Industrial Park, Emek Sara, POB 2049, Be'er Sheva, 8412316, Israel
Registrant Name : Sungjin Exim Co., Ltd.
Registration Date : 2005-08-31
Registration Number : 20050831-48-B-131-04
Manufacturer Name : Bioindustria LIMSpA
Manufacturer Address : Via Giustizia 1-15064 FRESONARA(AL)-ITALY (Via De Ambrosiis 2-4-6--15067 NOVI LIGURE-...
Registrant Name : Unimed Pharmaceutical Co., Ltd.
Registration Date : 2015-05-22
Registration Number : 20050831-48-B-131-04(2)
Manufacturer Name : Bioindustria LIMSpA_x000D_
Manufacturer Address : Via Giustizia 1-15064 FRESONARA(AL)-ITALY (Via De Ambrosiis 2-4-6-15067 NOVI LIGURE-I...
Registrant Name : Ildong Pharmaceutical Co., Ltd.
Registration Date : 2015-05-12
Registration Number : 20050831-48-B-131-04(1)
Manufacturer Name : Bioindustria LIMSpA_x000D_
Manufacturer Address : Via Giustizia 1-15064 FRESONARA(AL)-ITALY (Via De Ambrosiis 2-4-6--15067 NOVI LIGURE-...
Terazosin hydrochloride hydrate
Registrant Name : Bansen Co., Ltd.
Registration Date : 2017-11-15
Registration Number : 20171115-48-B-403-11
Manufacturer Name : CTX LIFE SCIENCES PVT. LIMIT...
Manufacturer Address : Block No. 251/P, 252/P, 235 To 255, 256/P, 258/P, 276/P, 278/P, 279 To 282, 283P, 284...
Registrant Name : Dongbang FTL Co., Ltd.
Registration Date : 2005-09-05
Registration Number : 20050905-48-B-133-06
Manufacturer Name : Dongbang FTL@Second Pharma C...
Manufacturer Address : 78 , 4th Street, Pharmaceutical Complex, Hyangnam-eup, Hwaseong-si, Gyeonggi-do, Kore...
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
NDC Package Code : 73435-029
Start Marketing Date : 2022-12-21
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63415-0116
Start Marketing Date : 2020-06-29
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65862-205
Start Marketing Date : 2023-11-15
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63809-2740
Start Marketing Date : 2000-06-12
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65372-1127
Start Marketing Date : 2007-10-19
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 48292-0040
Start Marketing Date : 2015-02-13
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...
About the Company : HRV Global is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It...
About the Company : Synthokem Labs Pvt Ltd is a privately owned company established in 1978, specializing in the production of Active Pharmaceutical Ingredients and Drug Intermediates. Operating acros...
About the Company : Founded in 1986 by Mr. P.V. Ramaprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born off a vision. The company comme...
About the Company : Bioindustria Laboratorio Italiano Medicinali L.I.M. S.p.A. has a long tradition in the pharmaceutical business and specializes in: large and small volume injectables with termin...
About the Company : Enaltec Labs was established in 2006 by a group of young & experienced professionals with the specific objective to develop & produce complex, small volume, technology driven produ...
About the Company : Jubilant Life Sciences Limited, is an integrated global pharmaceutical and life sciences company engaged in manufacture and supply of APIs, Solid Dosage Formulations, Radiopharmace...
About the Company : Teva API is a standalone business unit within Teva Pharmaceutical Industries, the world’s largest generic drug manufacturer. Employing over 4,000 professionals at 15 internationa...
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info : DISCN
Registration Country : USA
Brand Name : HYTRIN
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 2MG BASE
Packaging :
Approval Date : 1987-08-07
Application Number : 19057
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : HYTRIN
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1994-12-14
Application Number : 20347
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : TERAZOSIN HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 5MG BASE
Packaging :
Approval Date : 1998-03-30
Application Number : 74823
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : TERAZOSIN HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 10MG BASE
Packaging :
Approval Date : 2000-07-28
Application Number : 75667
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : TERAZOSIN HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 5MG BASE
Packaging :
Approval Date : 2004-12-20
Application Number : 75317
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : TEZRULY
Dosage Form : SOLUTION;ORAL
Dosage Strength : EQ 1MG BASE/ML
Packaging :
Approval Date : 2024-07-29
Application Number : 218139
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : Italy
Brand Name : Terazina
Dosage Form : Terazosina 5Mg 14 Joined' Oral Use
Dosage Strength : 14 CPR 5 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info : DISCN
Registration Country : USA
Brand Name : TERAZOSIN HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 10MG BASE
Packaging :
Approval Date : 2000-02-11
Application Number : 75140
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Spain
Brand Name : Deflox 2Mg 15 Tablets
Dosage Form : Tablet
Dosage Strength : 2 Mg/Tablet
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Spain
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Spain
Brand Name : Mayul 5Mg 28 Tablets Efg
Dosage Form : Tablet
Dosage Strength : 5 Mg/Tablet
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Spain
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : Terazina
Dosage Form : Terazosina 5Mg 14 Joined' Oral Use
Dosage Strength : 14 CPR Div 5 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Sweden
Brand Name : terazosin Accord
Dosage Form : TABLET
Dosage Strength : 2 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Sinalfa
Dosage Form : TABLET
Dosage Strength : 10 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Norway
Brand Name : Sinalfa
Dosage Form : Antic-calc Tablet
Dosage Strength : 5 mg
Packaging : Calendar Gasket
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Italy
Brand Name : Ezina
Dosage Form : Terazosina 2Mg 30 Joined' Oral Use
Dosage Strength : 30 CPR Div 2 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Terazina
Dosage Form : Terazosina 2Mg 30 Joined' Oral Use
Dosage Strength : 30 CPR 2 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Teraprt
Dosage Form : Terazosina 5Mg 14 Joined' Oral Use
Dosage Strength : 14 CPR Div 5 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : Terafluss
Dosage Form : Terazosina 5Mg 14 Joined' Oral Use
Dosage Strength : 14 CPR Div 5 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Spain
Brand Name : Zayasel 2Mg 15 Tablets Efg
Dosage Form : Tablet
Dosage Strength : 2 Mg/Tablet
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Spain
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Spain
Brand Name : Terazosin Alter 5Mg 30 Tablets Efg
Dosage Form : Tablet
Dosage Strength : 5 Mg/Tablet
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Spain
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Related Excipient Companies
Dosage Form : Tablet
Grade : Oral
Application : Coating Systems & Additives
Excipient Details : ACTILLETS™ are microcrystalline cellulose spheres used in advanced drug formulations as starter cores for drug layering and coating.
Pharmacopoeia Ref : NA
Technical Specs : Bulk density: 0.80
Ingredient(s) : Microcrystalline Cellulose
Dosage Form : Tablet
Grade : Oral
Dosage Form : Orodispersible Tablet
Grade : Oral
Application : Chewable & Orodispersible Aids
Excipient Details : CS90 is a directly compressible calcium carbonate with starch used for chewable tablets due to its smooth mouthfeel and creamy texture.
Pharmacopoeia Ref : NA
Technical Specs : PSD D50: 150-175, Tapped Density: 0.85
Ingredient(s) : Calcium Carbonate Excipient
Dosage Form : Orodispersible Tablet
Grade : Oral
Application : Chewable & Orodispersible Aids
Excipient Details : MS90 is a directly compressible magnesium hydroxide with starch used for chewable tablets due to its smooth mouthfeel and creamy texture.
Pharmacopoeia Ref : NA
Technical Specs : PSD D50: 150-170, Taped Density: 0.80
Ingredient(s) : Starch
Dosage Form : Injectable / Parenteral
Grade : Parenteral, Oral
Dosage Form : Injectable / Parenteral
Grade : Parenteral, Oral
Dosage Form : Tablet
Grade : Oral
Application : Emulsifying Agents
Excipient Details : HDK N20 Pharma is used as a pharmaceutical emulsifying agent in tablets, capsules, syrups, and solutions.
Dosage Form : Injectable / Parenteral
Grade : Parenteral, Oral
Dosage Form : Injectable / Parenteral
Grade : Parenteral, Oral
Dosage Form : Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Brand Name : Titanium dioxide PRETIOX ...
Application : Coating Systems & Additives
Excipient Details : Titanium dioxide Pretiox AV01FG is used as a coloring and coating agent in oral solid dosage forms such as capsules, tablets, granules, and pellets.
Pharmacopoeia Ref : Fami-QS, Kosher, Halal, OHSAS ...
Technical Specs : Ti 59.95% and O 40.05%
Ingredient(s) : Titanium Dioxide
Dosage Form : Tablet
Grade : Oral
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?